208 related articles for article (PubMed ID: 36194215)
1. Acute Pulmonary Embolism: A Review.
Freund Y; Cohen-Aubart F; Bloom B
JAMA; 2022 Oct; 328(13):1336-1345. PubMed ID: 36194215
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and Treatment of Lower Extremity Venous Thromboembolism: A Review.
Chopard R; Albertsen IE; Piazza G
JAMA; 2020 Nov; 324(17):1765-1776. PubMed ID: 33141212
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
[No Abstract] [Full Text] [Related]
4. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
5. Non-vitamin K antagonist oral anticoagulants for pulmonary embolism: who, where and for how long?
Howard LS
Expert Rev Respir Med; 2018 May; 12(5):387-402. PubMed ID: 29542359
[TBL] [Abstract][Full Text] [Related]
6. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.
Righini M; Van Es J; Den Exter PL; Roy PM; Verschuren F; Ghuysen A; Rutschmann OT; Sanchez O; Jaffrelot M; Trinh-Duc A; Le Gall C; Moustafa F; Principe A; Van Houten AA; Ten Wolde M; Douma RA; Hazelaar G; Erkens PM; Van Kralingen KW; Grootenboers MJ; Durian MF; Cheung YW; Meyer G; Bounameaux H; Huisman MV; Kamphuisen PW; Le Gal G
JAMA; 2014 Mar; 311(11):1117-24. PubMed ID: 24643601
[TBL] [Abstract][Full Text] [Related]
7. Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US.
Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
J Med Econ; 2015 Jun; 18(6):399-409. PubMed ID: 25586203
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism: contemporary diagnostic and therapeutic aspects.
Bounameaux H; Righini M; Perrier A
Vasa; 2008 Aug; 37(3):211-26. PubMed ID: 18690588
[TBL] [Abstract][Full Text] [Related]
9. Managing pulmonary embolism from presentation to extended treatment.
Cohen AT; Dobromirski M; Gurwith MM
Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
Rollins BM; Silva MA; Donovan JL; Kanaan AO
Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
Cohen AT; Hamilton M; Mitchell SA; Phatak H; Liu X; Bird A; Tushabe D; Batson S
PLoS One; 2015; 10(12):e0144856. PubMed ID: 26716830
[TBL] [Abstract][Full Text] [Related]
12. Acute pulmonary embolism: risk assessment, risk stratification and treatment options.
Piovella F; Iosub DI
Clin Respir J; 2016 Sep; 10(5):545-54. PubMed ID: 25619266
[TBL] [Abstract][Full Text] [Related]
13. Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial.
Freund Y; Chauvin A; Jimenez S; Philippon AL; Curac S; Fémy F; Gorlicki J; Chouihed T; Goulet H; Montassier E; Dumont M; Lozano Polo L; Le Borgne P; Khellaf M; Bouzid D; Raynal PA; Abdessaied N; Laribi S; Guenezan J; Ganansia O; Bloom B; Miró O; Cachanado M; Simon T
JAMA; 2021 Dec; 326(21):2141-2149. PubMed ID: 34874418
[TBL] [Abstract][Full Text] [Related]
14. Deep vein thrombosis: update on diagnosis and management.
Kruger PC; Eikelboom JW; Douketis JD; Hankey GJ
Med J Aust; 2019 Jun; 210(11):516-524. PubMed ID: 31155730
[TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.
Lee SR; Choi EK; Kwon S; Han KD; Jung JH; Cha MJ; Oh S; Lip GYH
Stroke; 2019 Aug; 50(8):2245-2249. PubMed ID: 31208303
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation.
Chan YH; Lee HF; See LC; Tu HT; Chao TF; Yeh YH; Wu LS; Kuo CT; Chang SH; Lip GYH
Chest; 2019 Sep; 156(3):529-543. PubMed ID: 31103697
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease.
Lopes RD; Thomas L; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Friend K; Mardekian J; Pan X; Yuce H; Jones WS
Am J Cardiol; 2021 Jun; 148():69-77. PubMed ID: 33667438
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients.
Kalani C; Awudi E; Alexander T; Udeani G; Surani S
Hosp Pract (1995); 2019 Oct; 47(4):181-185. PubMed ID: 31580732
[No Abstract] [Full Text] [Related]
20. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
